Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Exploratory Study of Inhaled Afatinib Dimaleate PK Profile [Phase 1]

View source ↗

Summary

This Phase 1 exploratory study investigates the pharmacokinetic profile of inhaled afatinib dimaleate in patients with lung cancer or oral cancer, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • afatinib dimaleate (afatinib)

Snippet

Sponsor: Petrov, Andrey | Conditions: Lung Cancer, Oral Cancer | Phase 1 | Status: NOT_YET_RECRUITING